Stanford Integrated Cardiovascular/Pulmonary Residency Research Training Program
- Institution
- Stanford University, CA
- Principal investigator
- Joseph C. Wu
- Funding
- $401K
- Duration
- 2020–2030
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY Stanford University School of Medicine is a site of unparalleled excellence in biomedical research and is an innovative leader in the fields of cardiovascular and pulmonary medicine. This renewal of the Stanford Integrated Cardiovascular/Pulmonary Residency Research Training Program provides research opportunities for talented individuals engaged in the residency stage of their medical training. The program draws resident investigators from the Stanford residency programs in Internal Medicine, Pediatrics, Cardiothoracic Surgery, Vascular Surgery, and Radiology, and place them in basic, translational, and clinical research laboratories affiliated with the Stanford Cardiovascular Institute (CVI) for a mentored research experience lasting 1-2 years. Upon completion of their clinical training, successful resident-investigators are eligible for K38 funding to support continued research efforts. For this renewal of our program, we will build upon the success of the previous four years in supporting residents across multi-disciplines. Research mentors for our StARR program are members of the Stanford CVI, which offers a unique platform to train the next generation and translational scientists. Major research programs within the CVI span Cardiac, Vascular, and Pulmonary disease categories, incorporating the disciplines of Genomics, Proteomics and Bioinformatics; Cellular and Molecular Biology; Imaging; Bioengineering; and Population Science. CVI scientists share a common interest in the mechanisms underlying cardiovascular and pulmonary medicine, and work together towards creating novel therapeutic, regenerative, and preventative approaches to cardiovascular and pulmonary diseases. Furthermore, the CVI offers multifaceted educational and career development programs that enhance the experience of R38 StARR trainees and prepare them to launch successful academic careers as clinician- scientists. Our renewal of the Stanford Integrated Cardiovascular/Pulmonary Residency Research Training Program will foster the career development and research training of resident-investigators who will continue on to careers as clinician-scientists in the fields of cardiovascular and pulmonary medicine.
Research team
- Michael Peter FischbeinPI
- Marlene RabinovitchPI
- Joseph C. WuPI
LOADING MOONBASE SCORE
Questions for Stanford University
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Stanford UniversityNot yet scored
Unraveling Proteasome Inhibitor-Induced Cardiovascular Toxicity through Integrative Multiomics
Mark Mercola · $717K · 2025–2028
- NIH · Stanford UniversityNot yet scored
1/2 A Phase 2 Study of Elafin (Tiprelestat) for the Treatment of Pulmonary Arterial Hypertension (PAH)
Marlene Rabinovitch · $2.0M · 2025–2026
- NIH · Stanford UniversityNot yet scored
Assessing Effects of Microgravity on Cardiovascular Aging with AI and 3D Organoids
Afshin Beheshti · $3.2M · 2025–2028